NCT03277924 2024-08-13ImmunoSarcGrupo Espanol de Investigacion en SarcomasPhase 1/2 Completed197 enrolled
NCT05204524 2022-01-24Temozolomide for Injection Combined With Epirubicin in First-line Treatment of LeiomyosarcomaChineseAMSPhase NA Unknown28 enrolled